Hospice News December 13, 2023
As Contessa Health pioneers a growing value-based palliative care-at-home program, they’ve encountered some learning curves when it comes to operating within a new payment system.
Contessa is a subsidiary of Amedisys (NASDAQ: AMED), which the home health and hospice provider acquired in 2021 for $250 million. Contessa’s specialty is high-acuity care in the home, including hospital-at-home and skilled nursing facility-at-home programs.
In June, Optum Health, a subsidiary of UnitedHealth Group (NYSE: UNH), agreed to acquire Amedisys for $3.3 billion.
Nevertheless, the company has been making substantial investments in building out its palliative care services. Since at least 2022, Contessa has been pursuing palliative care reimbursement through Medicare Advantage.
Earlier this year, the Amedisys subsidiary entered into its first full-risk Medicare...
Today's Sponsors
Today's Sponsor